hnRNP K and PCBP2, as oncogenes, contribute to the progression of CML-CP to CML-BC via distinct pathways through the activation of MYC mRNA translation and suppression of C/EBP α mRNA translation (58). This evidence concerns the gene PCBP2 and chronic myelogenous leukemia, BCR-ABL1 positive.